In the attached Revised Board Meeting intimation, corrected item no 3 of an appointment of Secretarial Auditor.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Mercury Laboratories has issued a revised intimation for its Board meeting scheduled on May 14, 2025, correcting item no. 3 regarding the appointment of a Secretarial Auditor. The board will consider and approve audited financial results for Q4 and FY ending March 31, 2025, along with the Directors' Report. It will also consider recommending a dividend for FY25, subject to shareholder approval. Additionally, the board will approve appointments of Internal Auditor and Cost Auditor for FY 2025-26, and finalize the date and notice for the 44th Annual General Meeting.
This is a routine procedural filing with a minor correction to the agenda. No material change for shareholders — the key items to watch are the upcoming audited FY25 results and any dividend announcement on May 14, 2025.